Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender

被引：8

作者：

Belani, C

von Pawel, J

Pluzanska, A

Gorbounova, V

Kaukel, E

Mattson, K

Ramlau, R

Fidias, P

Millward, M

Fossella, F

机构：

[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA

[2] Asklepios Fachkliniken Munchen Gauting, Gauting, Germany

[3] M Kopernik Mem Hosp, Lodz, Poland

[4] RAMS, Canc Res Ctr, Moscow, Russia

[5] AK Hamburg Harbug, Hamburg, Germany

[6] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland

[7] Reg Lung Dis Ctr, Poznan, Poland

[8] Massachusetts Gen Hosp, Boston, MA 02114 USA

[9] Sydney Canc Ctr, Camperdown, NSW, Australia

[10] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1016/S0169-5002(05)80945-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S235 / S236

页数：2